FEDERATED HERMES, INC. - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$696,419
-62.3%
204,829
-18.6%
0.00%
-60.0%
Q2 2023$1,848,532
-74.4%
251,501
-63.9%
0.01%
-72.2%
Q1 2023$7,207,773
-9.5%
695,731
+3.2%
0.02%
-18.2%
Q4 2022$7,960,413
-5.8%
674,040
+67.4%
0.02%
-12.0%
Q3 2022$8,453,000
+1135.8%
402,698
+1728.0%
0.02%
+1150.0%
Q2 2022$684,000
-94.4%
22,030
-92.6%
0.00%
-92.9%
Q1 2022$12,244,000
+42120.7%
298,208
+45289.3%
0.03%
Q4 2021$29,000
-99.6%
657
-99.5%
0.00%
-100.0%
Q3 2021$7,064,000
-22.8%
141,072
-3.0%
0.01%
-23.5%
Q2 2021$9,156,000
-59.7%
145,362
-40.6%
0.02%
-61.4%
Q1 2021$22,734,000
+9.9%
244,690
+6.0%
0.04%
+4.8%
Q4 2020$20,684,000
+11.1%
230,855
+28.1%
0.04%
-4.5%
Q3 2020$18,622,000
+66.3%
180,227
+27.3%
0.04%
+57.1%
Q2 2020$11,199,000
-10.1%
141,616
-34.2%
0.03%
-24.3%
Q1 2020$12,461,000
-10.5%
215,362
-16.6%
0.04%
+19.4%
Q4 2019$13,928,000
-8.0%
258,160
-10.9%
0.03%
-16.2%
Q3 2019$15,143,000
+15.9%
289,660
+7.1%
0.04%
+15.6%
Q2 2019$13,070,000
+9.2%
270,552
+14.2%
0.03%
+6.7%
Q1 2019$11,970,000
-14.3%
236,941
+0.5%
0.03%
-21.1%
Q4 2018$13,973,000
-3.3%
235,713
+7.4%
0.04%
+11.8%
Q3 2018$14,446,000
+69.8%
219,460
+30.3%
0.03%
+36.0%
Q2 2018$8,507,000
-47.4%
168,480
-45.2%
0.02%
-46.8%
Q1 2018$16,181,000
-29.1%
307,336
-37.4%
0.05%
-26.6%
Q4 2017$22,809,000
+147.2%
490,841
+115.2%
0.06%
+146.2%
Q3 2017$9,227,000
+11.1%
228,112
-6.9%
0.03%
+8.3%
Q2 2017$8,308,000
+20.8%
245,002
+3.4%
0.02%
+20.0%
Q1 2017$6,879,000
-13.0%
236,904
-1.6%
0.02%
-16.7%
Q4 2016$7,908,000
-12.0%
240,801
-15.5%
0.02%
-7.7%
Q3 2016$8,982,000
+55.2%
284,876
+38.5%
0.03%
+52.9%
Q2 2016$5,786,000
-29.7%
205,738
-9.2%
0.02%
-34.6%
Q1 2016$8,233,000
-7.9%
226,480
+1.3%
0.03%
-7.1%
Q4 2015$8,941,000
+2323.0%
223,469
+1626.3%
0.03%
+2700.0%
Q3 2015$369,00012,9450.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Zebra Capital Management LLC 22,111$908,0002.08%
Global Alpha Capital Management Ltd. 460,530$18,909,0001.62%
AIMZ Investment Advisors, LLC 70,625$2,900,0001.19%
Bridge City Capital, LLC 39,835$1,636,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 560,409$23,010,0000.53%
EARNEST PARTNERS LLC 2,071,376$85,051,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 302,721$12,430,0000.50%
SummerHaven Investment Management, LLC 14,476$594,0000.34%
Ridgewood Investments LLC 10,004$411,0000.27%
AtonRa Partners 11,505$472,0000.26%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders